Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-025160
Filing Date
2004-02-17
Accepted
2004-02-17 16:46:06
Documents
9
Period of Report
2003-11-30

Document Format Files

Seq Description Document Type Size
1 FROM 10-K d10k.htm 10-K 1751684
3 STOCK INCENTIVE PLAN dex1016.htm EX-10.16 62394
4 SECOND ADMENDMENT TO CREDIT AGREEMENT dex1021.htm EX-10.21 24142
5 MEMORANDUM OF UNDERSTANDING DATED DECEMBER 19, 2003 dex1022.htm EX-10.22 42913
6 SUBSIDIARIES dex21.htm EX-21 5874
7 CONSENT OF INDEPENDENT AUDITORS dex23.htm EX-23 2360
8 CERTIFICATION REQUIRED BY RULE 13A-14(A) dex31.htm EX-31 17200
9 CERTIFICATION REQUIRED BY RULE 13A-14(B) dex32.htm EX-32 5382
10 SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS dex991.htm EX-99.1 34091
  Complete submission text file 0001193125-04-025160.txt   1948648
Mailing Address 1715 W 38TH ST CHATTANOOGA TN 37409
Business Address 1715 W 38TH ST CHATTANOOGA TN 37409 4238214571
CHATTEM INC (Filer) CIK: 0000019520 (see all company filings)

EIN.: 620156300 | State of Incorp.: TN | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-05905 | Film No.: 04609515
SIC: 2834 Pharmaceutical Preparations